These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Loss of anti-cataleptic effect of scopolamine in mice lacking muscarinic acetylcholine receptor subtype 4. Karasawa H; Taketo MM; Matsui M Eur J Pharmacol; 2003 May; 468(1):15-9. PubMed ID: 12729838 [TBL] [Abstract][Full Text] [Related]
3. Dopaminergic and cholinergic interaction in cataleptic responses in mice. Ushijima I; Kawano M; Kaneyuki H; Suetsugi M; Usami K; Hirano H; Mizuki Y; Yamada M Pharmacol Biochem Behav; 1997 Sep; 58(1):103-8. PubMed ID: 9264077 [TBL] [Abstract][Full Text] [Related]
4. The potency and efficacy of anticholinergics to inhibit haloperidol-induced catalepsy in rats correlates with their rank order of affinities for the muscarinic receptor subtypes. Erosa-Rivero HB; Bata-García JL; Alvarez-Cervera FJ; Heredia-López FJ; Góngora-Alfaro JL Neuropharmacology; 2014 Jun; 81():176-87. PubMed ID: 24534110 [TBL] [Abstract][Full Text] [Related]
5. Combined treatment of quetiapine with haloperidol in animal models of antipsychotic effect and extrapyramidal side effects: comparison with risperidone and chlorpromazine. Tada M; Shirakawa K; Matsuoka N; Mutoh S Psychopharmacology (Berl); 2004 Oct; 176(1):94-100. PubMed ID: 15083255 [TBL] [Abstract][Full Text] [Related]
6. Involvement of Striatal Cholinergic Interneurons and M1 and M4 Muscarinic Receptors in Motor Symptoms of Parkinson's Disease. Ztaou S; Maurice N; Camon J; Guiraudie-Capraz G; Kerkerian-Le Goff L; Beurrier C; Liberge M; Amalric M J Neurosci; 2016 Aug; 36(35):9161-72. PubMed ID: 27581457 [TBL] [Abstract][Full Text] [Related]
7. Modulation of prepulse inhibition through both M(1) and M (4) muscarinic receptors in mice. Thomsen M; Wess J; Fulton BS; Fink-Jensen A; Caine SB Psychopharmacology (Berl); 2010 Feb; 208(3):401-16. PubMed ID: 20013114 [TBL] [Abstract][Full Text] [Related]
8. Blockade of muscarinic acetylcholine receptors facilitates motivated behaviour and rescues a model of antipsychotic-induced amotivation. Hailwood JM; Heath CJ; Phillips BU; Robbins TW; Saksida LM; Bussey TJ Neuropsychopharmacology; 2019 May; 44(6):1068-1075. PubMed ID: 30478410 [TBL] [Abstract][Full Text] [Related]
9. Interplay between adenosine receptor antagonist and cyclooxygenase inhibitor in haloperidol-induced extrapyramidal effects in mice. Arora D; Mudgal J; Nampoothiri M; Mallik SB; Kinra M; Hall S; Anoopkumar-Dukie S; Grant GD; Rao CM Metab Brain Dis; 2018 Aug; 33(4):1045-1051. PubMed ID: 29516413 [TBL] [Abstract][Full Text] [Related]
10. Effects of adjunct galantamine to risperidone, or haloperidol, in animal models of antipsychotic activity and extrapyramidal side-effect liability: involvement of the cholinergic muscarinic receptor. Wadenberg ML; Fjällström AK; Federley M; Persson P; Stenqvist P Int J Neuropsychopharmacol; 2011 Jun; 14(5):644-54. PubMed ID: 20701827 [TBL] [Abstract][Full Text] [Related]
11. Enhancement of Haloperidol-Induced Catalepsy by GPR143, an L-Dopa Receptor, in Striatal Cholinergic Interneurons. Arai M; Suzuki E; Kitamura S; Otaki M; Kanai K; Yamasaki M; Watanabe M; Kambe Y; Murata K; Takada Y; Arisawa T; Kobayashi K; Tajika R; Miyazaki T; Yamaguchi M; Lazarus M; Hayashi Y; Itohara S; de Kerchove d'Exaerde A; Nawa H; Kim R; Bito H; Momiyama T; Masukawa D; Goshima Y J Neurosci; 2024 Mar; 44(11):. PubMed ID: 38286627 [TBL] [Abstract][Full Text] [Related]